Celcuity Corp (CELC): חובות להיוון בספרים

The daily price chart for Celcuity Inc. (CELC) reflects the performance of an oncology diagnostics innovator utilizing a unique live-cell analysis system for precise therapy selection, which constitutes 0.00. Business efficiency relies on temperature-controlled express air transport of biosamples. The stability of R&D processes is ensured by a cohesive staff of biologists and the targeted hiring of specialized clinical trial managers.

This indicator measures the share of total liabilities within the equity structure, determining the company's degree of dependence on borrowed funds. For Celcuity Inc. (CELC), which is developing the CELx platform for pharma behemoths, moderate leverage confirms financial stability while scaling B2B partnerships, as reflected in the total debt-to-book capitalization chart, which demonstrates a balance between security and the pace of expansion.